267 related articles for article (PubMed ID: 1353535)
1. Site specific screening for point mutations in ornithine transcarbamylase deficiency.
Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A
J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535
[TBL] [Abstract][Full Text] [Related]
2. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
[TBL] [Abstract][Full Text] [Related]
3. Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.
Hentzen D; Pelet A; Feldman D; Rabier D; Berthelot J; Munnich A
Hum Genet; 1991 Dec; 88(2):153-6. PubMed ID: 1721894
[TBL] [Abstract][Full Text] [Related]
4. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
Climent C; Rubio V
Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
[TBL] [Abstract][Full Text] [Related]
5. Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.
Matsuura T; Hoshide R; Kiwaki K; Komaki S; Koike E; Endo F; Oyanagi K; Suzuki Y; Kato I; Ishikawa K
Hum Mutat; 1994; 3(4):402-6. PubMed ID: 8081398
[No Abstract] [Full Text] [Related]
6. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
[TBL] [Abstract][Full Text] [Related]
7. Seven new mutations in the human ornithine transcarbamylase gene.
Tuchman M; Plante RJ; McCann MT; Qureshi AA
Hum Mutat; 1994; 4(1):57-60. PubMed ID: 7951259
[No Abstract] [Full Text] [Related]
8. Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism.
Tuchman M; Holzknecht RA; Gueron AB; Berry SA; Tsai MY
Pediatr Res; 1992 Nov; 32(5):600-4. PubMed ID: 1480464
[TBL] [Abstract][Full Text] [Related]
9. Mutations and polymorphisms in the human ornithine transcarbamylase gene.
Tuchman M
Hum Mutat; 1993; 2(3):174-8. PubMed ID: 8364586
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
[TBL] [Abstract][Full Text] [Related]
11. The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.
Matsuda I; Tanase S
Am J Med Genet; 1997 Sep; 71(4):378-83. PubMed ID: 9286441
[TBL] [Abstract][Full Text] [Related]
12. [Genetic counseling in ornithine carbamoyltransferase deficiency].
Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
[TBL] [Abstract][Full Text] [Related]
13. Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene.
Yamaguchi S; Brailey LL; Morizono H; Bale AE; Tuchman M
Hum Mutat; 2006 Jul; 27(7):626-32. PubMed ID: 16786505
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
[TBL] [Abstract][Full Text] [Related]
15. Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity.
Hoshide R; Matsuura T; Sagara Y; Kubo T; Shimadzu M; Endo F; Matsuda I
Am J Med Genet; 1996 Aug; 64(3):459-64. PubMed ID: 8862622
[TBL] [Abstract][Full Text] [Related]
16. Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency.
Maddalena A; Spence JE; O'Brien WE; Nussbaum RL
J Clin Invest; 1988 Oct; 82(4):1353-8. PubMed ID: 3170748
[TBL] [Abstract][Full Text] [Related]
17. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
[TBL] [Abstract][Full Text] [Related]
18. Single-strand conformational polymorphism and direct sequencing applied to carrier testing in families with ornithine transcarbamylase deficiency.
Tsai MY; Holzknecht RA; Tuchman M
Hum Genet; 1993 May; 91(4):321-5. PubMed ID: 8099056
[TBL] [Abstract][Full Text] [Related]
19. [Ornithine transcarbamylase deficiency].
Hata A
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):500-4. PubMed ID: 2908395
[No Abstract] [Full Text] [Related]
20. Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.
Tuchman M; Matsuda I; Munnich A; Malcolm S; Strautnieks S; Briede T
Am J Med Genet; 1995 Jan; 55(1):67-70. PubMed ID: 7702100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
